Cerebral Ischemia in Patients on Direct Oral Anticoagulants

Beitrag in einer Fachzeitschrift

Details zur Publikation

Autorinnen und Autoren: Macha K, Marsch A, Siedler G, Breuer L, Strasser E, Engelhorn T, Schwab S, Kallmünzer B
Zeitschrift: Stroke
Jahr der Veröffentlichung: 2019
Band: 50
Heftnummer: 4
Seitenbereich: 873-879
ISSN: 1524-4628


Background and Purpose- In patients with ischemic stroke on therapy with vitamin K antagonists, stroke severity and clinical course are affected by the quality of anticoagulation at the time of stroke onset, but clinical data for patients using direct oral anticoagulants (DOACs) are limited. Methods- Data from our registry including all patients admitted with acute cerebral ischemia while taking oral anticoagulants for atrial fibrillation between November 2014 and October 2017 were investigated. The activity of vitamin K antagonists was assessed using the international normalized ratio on admission and categorized according to a threshold of 1.7. DOAC plasma levels were measured using the calibrated Xa-activity (apixaban, rivaroxaban, and edoxaban) or the Hemoclot-assay (dabigatran) and categorized into low (<50 ng/mL), intermediate (50-100 ng/mL), or high (>100 ng/mL). Primary objective was the association between anticoagulant activity and clinical and imaging characteristics. Results- Four hundred sixty patients were included (49% on vitamin K antagonists and 51% on DOAC). Patients on vitamin K antagonists with low international normalized ratio values had higher scores on the National Institutes of Health Stroke Scale and a higher risk of large vessel occlusion on admission. For patients on DOAC, plasma levels were available in 75.6% and found to be low in 49 (27.7%), intermediate in 41 (23.2%), and high in 87 patients (49.2%). Low plasma levels were associated with higher National Institutes of Health Stroke Scale scores on admission (low: 8 [interquartile range, 3-15] versus intermediate: 4 [1-11] versus high: 3 [0-8]; P<0.001) and higher risk of persisting neurological deficits or cerebral infarction on imaging (85.7% versus 75.6% versus 54.0%; P<0.001). Low DOAC plasma levels were an independent predictor of large vessel occlusion (odds ratio, 3.84 [95% CI, 1.80-8.20]; P=0.001). Conclusions- The activity of anticoagulation measured by specific DOAC plasma levels on admission is associated with stroke severity and presence of large vessel occlusion.

FAU-Autorinnen und Autoren / FAU-Herausgeberinnen und Herausgeber

Kallmünzer, Bernd PD Dr.
Neurologische Klinik
Macha, Kosmas
Medizinische Fakultät
Marsch, Armin
Neurologische Klinik
Schwab, Stefan Prof. Dr.
Lehrstuhl für Neurologie
Siedler, Gabriela Dr. med.
Neurologische Klinik
Strasser, Erwin Prof. Dr.
Medizinische Fakultät


Macha, K., Marsch, A., Siedler, G., Breuer, L., Strasser, E., Engelhorn, T.,... Kallmünzer, B. (2019). Cerebral Ischemia in Patients on Direct Oral Anticoagulants. Stroke, 50(4), 873-879. https://dx.doi.org/10.1161/STROKEAHA.118.023877

Macha, Kosmas, et al. "Cerebral Ischemia in Patients on Direct Oral Anticoagulants." Stroke 50.4 (2019): 873-879.


Zuletzt aktualisiert 2019-26-07 um 09:34